Smith & Nephew in pounds 41m facelift
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SMITH & NEPHEW, the healthcare concern, has announced a pounds 41m investment that the company said would transform its medical division over the next five years, writes Russell Hotten.
Smith is redeveloping its site at Hull to handle expansion of its wound healing, casting and support businesses to serve growing markets, principally in Japan, Germany and the US.
Nicholas Hildyard, managing director, said it was the largest single capital investment in the company's history. It will be financed out of cash and future profits. The investment, stretched over three years, includes a pounds 2.65m DTI grant.
Mr Hildyard estimated that over five to six years the project would add 10 per cent a year to the medical division's annual sales of pounds 300m. Analysts said the company would need to address its capacity problems if it was to expand in Japan and the US.
Two-thirds of products made in Hull are exported, and by 1996 this figure should rise to 85 per cent.
Last month the company announced interim pre-tax profits on continuing operations up 19 per cent to pounds 82.2m on sales of pounds 489m. Smith took the entire cost of a pounds 148m loss on the sale of Ioptex, its US lenses maker, at the half-year.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments